Patient sample
| Monotherapy (n=6502) | Fixed combination (n=867) | Free combination (n=663) | Total (n=8032) | |
|---|---|---|---|---|
| Age; m (SD) | 60.0 (15.6) | 60.7 (14.0) | 62.9 (13.3) | 60.3 (15.2) |
| (95% CI) | (59.6 to 60.3) | (59.7 to 61.6) | (61.8 to 63.9) | (59.9 to 60.6) |
| Gender | ||||
| Male; % | 42.0 | 45.4 | 56.6 | 43.5 |
| (95% CI) | (40.8 to 43.2) | (42.0 to 48.7) | (52.7 to 60.4) | (42.4 to 44.6) |
| Female; % | 58.0 | 54.6 | 43.4 | 56.5 |
| (95% CI) | (56.8 to 59.2) | (51.3 to 58.0) | (39.6 to 47.3) | (55.4 to 57.6) |